The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2015

Filed:

Apr. 05, 2010
Applicants:

Ta-wei D. Liu, Hsinchu, TW;

Yen-lin Chen, Hsinchu, TW;

Ming-der Wu, Hsinchu, TW;

Ming-jen Cheng, Hsinchu, TW;

Hui-ping Chen, Hsinchu, TW;

Wen-jung Wu, Hsinchu, TW;

Kai-ping Chen, Hsinchu, TW;

Yu-shan Lin, Hsinchu, TW;

Gwo-fang Yuan, Hsinchu, TW;

Inventors:

Ta-Wei D. Liu, Hsinchu, TW;

Yen-Lin Chen, Hsinchu, TW;

Ming-Der Wu, Hsinchu, TW;

Ming-Jen Cheng, Hsinchu, TW;

Hui-Ping Chen, Hsinchu, TW;

Wen-Jung Wu, Hsinchu, TW;

Kai-Ping Chen, Hsinchu, TW;

Yu-Shan Lin, Hsinchu, TW;

Gwo-Fang Yuan, Hsinchu, TW;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A61K 31/365 (2006.01);
U.S. Cl.
CPC ...
A61K 31/365 (2013.01);
Abstract

The present invention concerns the uses of an azaphilone compound of formula (I): formula (I): or a pharmaceutically acceptable derivative thereof as described in the specification for modulation of the activity of a nuclear hormone receptor and for prevention and/or treatment of a disease or disorder related to nuclear hormone receptor activity.


Find Patent Forward Citations

Loading…